An apparel top for use by a user is worn about a user torso and a user waist. The top includes an outer shell portion having first and second panels, a back panel, shell outside and inside surfaces, and a bottom edge. The apparel top includes a snow gaiter having upper and lower gaiter edges, first and second gaiter ends, and gaiter inner and outer surfaces. The upper gaiter edge is attached to the outer shell portion at the shell inside surface and extends along the first front panel, the back panel and the second front panel. The lower gaiter edge is generally positionable about the user waist relative to the user torso with the lower gaiter edge extending away from the user torso. The top includes a liquid bladder sized and configured to be inflated with a liquid. The liquid bladder is attached to the snow gaiter.

The present disclosure relates to compositions and methods of killing cells in vitro or in vivo. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody-IR700 molecule, wherein the antibody specifically binds to the cell surface protein. In particular examples the antibody recognizes a tumor-specific antigen on the surface of a tumor cell. The cell is subsequently irradiated, such as at a wavelength of 660 to 740 nm at a dose of at least 1 J cm.sup.2, thereby killing the cell. Also provided are wearable devices that include an article of clothing, jewelry, or covering; and an NIR LED incorporated into the article, which can be used with the disclosed methods.

The present disclosure relates to compositions and methods of killing cells. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody-IR700 molecule, wherein the antibody specifically binds to the cell surface protein, such as a tumor-specific antigen on the surface of a tumor cell. The cell is subsequently irradiated, such as at a wavelength of 660 to 740 nm at a dose of at least 1 J cm.sup.2. The cell is also contacted with one or more therapeutic agents (such as an anti-cancer agent), for example about 0 to 8 hours after irradiating the cell, thereby killing the cell. Also provided are methods of imaging cell killing in real time, using fluorescence lifetime imaging. Also provided are wearable devices that include an article of clothing, jewelry, or covering; and an NIR LED incorporated into the article, which can be used with the disclosed methods.

An impact transfer device comprising a device body, an impact zone shield associated with a first body region, and at least one body contact associated with a second body region, each body contact comprising at least one contact surface, and at least one attachment structure configured to attach the impact transfer device to a person. At least a portion of a force applied to the impact surface is transferred to the second body region of the person through the contact surfaces.

A multiview body camera system with a vest, a helmet, shoulder pads, camera units providing video, directional microphones providing audio, sensors providing motion detection and other functions is described herein. A control module controls camera units, microphones, sensors and all other circuitry. A tamper-proof locking compartment containing elements of the body camera system is operable by a remote control signal transmitted from an authorized party or by a security code. The body camera system features voice command recognition, real time monitoring, recording, storing, remote reporting; alerts the wearer of impending threats, such as approaching cars, persons, objects or gunshots and may incorporate a visor that provides a panoramic view. The body camera integrates all components internally. Bullet resistant material is used in the construction of the vest and helmet. The device operates continuously, and the wearer cannot disrupt the operation without consequence. All recorded data is archived an internal memory.

The present disclosure relates to compositions and methods of killing cells. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody-IR700 molecule, wherein the antibody specifically binds to the cell surface protein, such as a tumor-specific antigen on the surface of a tumor cell. The cell is subsequently irradiated, such as at a wavelength of 660 to 740 nm at a dose of at least 1 J cm.sup.2. The cell is also contacted with one or more therapeutic agents (such as an anti-cancer agent), for example about 0 to 8 hours after irradiating the cell, thereby killing the cell. Also provided are methods of imaging cell killing in real time, using fluorescence lifetime imaging. Also provided are wearable devices that include an article of clothing, jewelry, or covering; and an NIR LED incorporated into the article, which can be used with the disclosed methods.

The present disclosure relates to compositions and methods of killing cells in vitro or in vivo. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody-IR700 molecule, wherein the antibody specifically binds to the cell surface protein. In particular examples the antibody recognizes a tumor-specific antigen on the surface of a tumor cell. The cell is subsequently irradiated, such as at a wavelength of 660 to 740 nm at a dose of at least 1 J cm.sup.2, thereby killing the cell. Also provided are wearable devices that include an article of clothing, jewelry, or covering; and an NIR LED incorporated into the article, which can be used with the disclosed methods.

An attachable pocket is configured to be attached to a garment at any desired location along a surface of the garment. The attachable pocket includes a sheet that forms a chamber that is used to store objects such that the attachable pocket protects the objects from elements or debris. An opening into the chamber is closed with a closure to block access into the chamber and to seal the attachable pocket with the object in the chamber.

An individual who has had a limb amputation and wears a prosthetic limb on an amputated residual limb may have a difficult time adjusting the prosthetic limb discreetly in a public setting. Described herein are articles of clothing, access opening systems, clothing cuffs, or devices for securing a prosthetic limb to a residual limb fitted with the prosthetic limb and for providing access to the prosthetic limb discreetly without removing a substantial portion of the clothing.

A garment comprising protective apparel fabric, a fastener assembly for joining a first and a second area of the protective apparel fabric, and a closing flap for covering the fastener assembly, the closing flap attached to the outer garment surface of first area of protective apparel fabric, the closing flap having a size and shape such that the covering area of the closing flap fully covers the fastener assembly when the fastener assembly is closed, the closing flap having an average bending rigidity that is at least 7.5 percent greater than the average bending rigidity of the protective apparel fabric; the color and/or visual marking or pattern of the closing flap can be different from or distinct from other parts of the garment.